End-of-day quote
Shenzhen S.E.
23:00:00 14/05/2024 BST
5-day change
1st Jan Change
8.86
CNY
-2.53%
-8.57%
-23.09%
Fiscal Period: December
2018
2019
2020
2021
2022
2023
Capitalization
1
11,312
12,979
13,348
6,804
4,034
4,073
Enterprise Value (EV)
1
10,888
12,766
13,074
6,781
4,044
4,024
P/E ratio
42
x
33.3
x
63.4
x
-62.6
x
-13.9
x
-9.52
x
Yield
-
-
-
-
-
-
Capitalization / Revenue
7.86
x
8.02
x
8.67
x
4.78
x
2.95
x
3.54
x
EV / Revenue
7.56
x
7.89
x
8.49
x
4.77
x
2.96
x
3.49
x
EV / EBITDA
26.9
x
25
x
44.4
x
135
x
-96.8
x
-40.7
x
EV / FCF
-104
x
-73.5
x
113
x
-32.4
x
272
x
19.4
x
FCF Yield
-0.96%
-1.36%
0.89%
-3.09%
0.37%
5.14%
Price to Book
5.94
x
5.57
x
5.59
x
2.75
x
1.75
x
2.18
x
Nbr of stocks (in thousands)
354,606
354,606
350,698
350,698
353,521
353,521
Reference price
2
31.90
36.60
38.06
19.40
11.41
11.52
Announcement Date
23/04/19
14/04/20
28/04/21
14/04/22
07/04/23
24/04/24
Fiscal Period: December
2018
2019
2020
2021
2022
2023
Net sales
1
1,440
1,618
1,540
1,422
1,368
1,151
EBITDA
1
405
511.2
294.7
50.17
-41.78
-98.87
EBIT
1
338.4
429.1
218.6
-46.41
-132.4
-198.8
Operating Margin
23.51%
26.53%
14.19%
-3.26%
-9.68%
-17.27%
Earnings before Tax (EBT)
1
310.9
445.7
245.3
-120.4
-283.3
-453.4
Net income
1
268.1
390.6
210.7
-110.8
-254.8
-427.2
Net margin
18.62%
24.15%
13.68%
-7.79%
-18.62%
-37.1%
EPS
2
0.7600
1.100
0.6000
-0.3100
-0.8200
-1.210
Free Cash Flow
1
-104.3
-173.8
116
-209.4
14.89
207
FCF margin
-7.25%
-10.74%
7.53%
-14.73%
1.09%
17.97%
FCF Conversion (EBITDA)
-
-
39.35%
-
-
-
FCF Conversion (Net income)
-
-
55.06%
-
-
-
Dividend per Share
-
-
-
-
-
-
Announcement Date
23/04/19
14/04/20
28/04/21
14/04/22
07/04/23
24/04/24
Fiscal Period: December
2022 Q1
Net sales
-
EBITDA
-
EBIT
-
Operating Margin
-
Earnings before Tax (EBT)
-
Net income
1
-11.93
Net margin
-
EPS
2
-0.0400
Dividend per Share
-
Announcement Date
14/04/22
Fiscal Period: December
2018
2019
2020
2021
2022
2023
Net Debt
1
-
-
-
-
10.1
-
Net Cash position
1
424
212
274
22.7
-
48.4
Leverage (Debt/EBITDA)
-
-
-
-
-0.2419
x
-
Free Cash Flow
1
-104
-174
116
-209
14.9
207
ROE (net income / shareholders' equity)
14.8%
18.1%
8.63%
-4.44%
-10.4%
-20.1%
ROA (Net income/ Total Assets)
10.6%
10.2%
4.33%
-0.86%
-2.46%
-4.18%
Assets
1
2,525
3,821
4,867
12,920
10,343
10,218
Book Value Per Share
2
5.370
6.570
6.810
7.040
6.510
5.270
Cash Flow per Share
2
1.190
1.160
1.790
1.180
0.9400
0.9600
Capex
1
166
295
113
337
73.3
55.1
Capex / Sales
11.52%
18.25%
7.31%
23.67%
5.36%
4.79%
Announcement Date
23/04/19
14/04/20
28/04/21
14/04/22
07/04/23
24/04/24
1st Jan change
Capi.
-23.09% 434M -15.71% 8.57B +67.50% 4.3B -2.27% 2.46B -42.54% 2.31B -6.49% 1.93B -20.45% 1.53B -41.24% 1.2B +10.26% 1.14B +16.61% 986M
Medical & Diagnostic Laboratories
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
marketscreener.com**derivatives**en**/dynamic-chart/**Premium**Expert**Access**Annual**Monthly**Discover our Free Content to Help You Better Understand the Stock Market.**#ffffff**/registration/member/**#004eff**#000000**100% Free Registration**1**